We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: On Patenting Genes and Their Correlations: It’s a Chicken-Egg Problem
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Innovations > On Patenting Genes and Their Correlations: It’s a Chicken-Egg Problem
BusinessMedical Innovations

On Patenting Genes and Their Correlations: It’s a Chicken-Egg Problem

Kenneth Walz
Kenneth Walz
Share
3 Min Read
SHARE

Last month, my colleague Shane Climie wrote a post inspired by an article in the New Yo

Last month, my colleague Shane Climie wrote a post inspired by an article in the New York Times (“How Bright Promise in Cancer Testing Fell Apart”), which exposed disturbing and cautionary insights into the application of genetic testing technology. Today, I’m responding to a recent New York Times article in which reporter Andrew Pollack wrote of challenges facing Myriad Genetics in spite of the company having received a victory when a federal appeals court upheld the company’s patents on two human genes ­– and the validity of gene patents.

It’s worth checking out Andy’s article for more context, but here are my two cents on some of the issues covered:

  • My hunch is that eventually courts will rule (and in so doing give clear guidance) that while products of nature cannot be patented, companies likely will be able to continue to patent the knowledge that a gene or other physiological marker (all of which are “products of nature”) correlates to a particular condition, disease, and/or drug response. This is a key point of clarity that is needed in order for the field of “personalized medicine” to reach its full potential.
  • As is clear from some of the expert and company representative quotes in the article, what we’re looking at here is a chicken-egg situation. In most cases, clinical validation that a gene correlates with a particular condition (or another type of correlation) is made possible by the investment of capital in a private company’s research, and the investors depend on the research entity having patent protection to help generate a return on their investment. On the other hand, society as a whole (i.e., public health) may be worse-off if use of the knowledge of the correlation is not allowed or made widely available.
  • And, as we’ve written about in previous blog posts, whole genome sequencing will soon be done at a relatively low cost but how the resulting data is interpreted and used will continue to present challenges and be subject to the competing forces described above.

As life science consults with deep experience in medical devices and in genomics research, this issue is fascinating to the Popper and Company team. How does it strike you? Do you agree that this boils down to a chicken vs. egg situation or do you see it differently? Do you have any specific insights on the Myriad situation or similar business examples? We welcome your thoughts on this important topic.

More Read

Bacteria and Mobile Devices
Stem Cell Therapy FDA Approved for Wrinkles
SaaS Firm Crowdfunds “People-Focused” Image Sharing
Meaningful Use Stage 3: The Buzz About APIs
Consumers Prefer Marketing Collateral by Post to Email

This post originally appeared on the Popper and Company blog.

TAGGED:gene patentsgeneticsgenomics researchpatenting genespersonalized medicine
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Flat editorial illustration: Healthcare volunteer communication as a two-way, coordinator-supported process for confirming schedu
How to Manage Volunteer Communication in Healthcare: 5 Tactical Steps and Software Options
Global Healthcare
November 18, 2026
The Nervous System Reset Guide: Simple Ways To Manage Stress -- AI-generated illustration
The Nervous System Reset Guide: Simple Ways To Manage Stress
Infographics Mental Health
November 14, 2026
Flat editorial illustration: A single digital quality-management platform connects document control, electronic approval, audit r
6 Best QMS Software Platforms for ISO 13485 and FDA Part 820 (QMSR)
Global Healthcare Policy & Law
November 12, 2026
Flat editorial illustration: Healthcare editorial illustration about accurate patient intake connecting registration, clinical re
The Role of Patient Data Accuracy in Healthcare Operations
Global Healthcare Policy & Law
November 11, 2026

You Might also Like

Google and ‘Rogue Pharmacy’ Ads Complaint

May 13, 2011

Using Teleradiology to Become Independent from RIS [VIDEO]

August 7, 2014
rating quality of healthcare service
Business

Quality of Service in Healthcare: Have You Assessed Yours?

June 13, 2014
Image
BusinessWellness

RAND Corporation (Briefly) Publishes Sobering Report On Workplace Wellness Programs

June 9, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?